Lorazepam
Product Images NDC 66336-363

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 66336-363). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Ndc 66336-0363-xx (Ndc 66336 0363 Xx Actavis)

Ndc 66336-0363-xx (Ndc 66336 0363 Xx Actavis)
This is a bulk source data of Lorazepam 0.5mg medication tablets, distributed by Actavis Elizabeth LLC. The tablets are white to off-white, round and imprinted with a company logo and "57". Each bottle has 4 tablets and the each tablet is to be taken orally every time it is needed. There is a warning that the drug may cause drowsiness and may impair the ability to drive a car. It also cautions that the drug should not be transferred to any person other than the patient for whom it was prescribed. The drug should be kept out of reach of children and should be stored at 77°F. There is a reference to USP guidelines. The pedigree # is 0487515011. The listed company is located in Santa Ana, CA 92704.*
FDA Label Image

Image Description (Cdd3dc93 Figure 01)

Image Description (Cdd3dc93 Figure 01)
FDA Label Image

Cdd3dc93-figure-02 (Cdd3dc93 Figure 02)

Cdd3dc93-figure-02 (Cdd3dc93 Figure 02)
FDA Label Image

Cdd3dc93-figure-03 (Cdd3dc93 Figure 03)

Cdd3dc93-figure-03 (Cdd3dc93 Figure 03)
FDA Label Image

Cdd3dc93-figure-04 (Cdd3dc93 Figure 04)

Cdd3dc93-figure-04 (Cdd3dc93 Figure 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.